852 related articles for article (PubMed ID: 32049051)
21. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
Anghelina D; Lam E; Falck-Pedersen E
J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
[TBL] [Abstract][Full Text] [Related]
22. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
Johnson BM; Uchimura T; Gallovic MD; Thamilarasan M; Chou WC; Gibson SA; Deng M; Tam JW; Batty CJ; Williams J; Matsushima GK; Bachelder EM; Ainslie KM; Markovic-Plese S; Ting JP
J Immunol; 2021 May; 206(9):2015-2028. PubMed ID: 33820855
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles.
de Couto G; Jaghatspanyan E; DeBerge M; Liu W; Luther K; Wang Y; Tang J; Thorp EB; Marbán E
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2082-2096. PubMed ID: 31434491
[TBL] [Abstract][Full Text] [Related]
25. Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.
Zhou C; Chen X; Planells-Cases R; Chu J; Wang L; Cao L; Li Z; López-Cayuqueo KI; Xie Y; Ye S; Wang X; Ullrich F; Ma S; Fang Y; Zhang X; Qian Z; Liang X; Cai SQ; Jiang Z; Zhou D; Leng Q; Xiao TS; Lan K; Yang J; Li H; Peng C; Qiu Z; Jentsch TJ; Xiao H
Immunity; 2020 May; 52(5):767-781.e6. PubMed ID: 32277911
[TBL] [Abstract][Full Text] [Related]
26. Ectopic expression of cGAS in
Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
[TBL] [Abstract][Full Text] [Related]
27. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
[TBL] [Abstract][Full Text] [Related]
28. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
[TBL] [Abstract][Full Text] [Related]
29. IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP.
Jønsson KL; Laustsen A; Krapp C; Skipper KA; Thavachelvam K; Hotter D; Egedal JH; Kjolby M; Mohammadi P; Prabakaran T; Sørensen LK; Sun C; Jensen SB; Holm CK; Lebbink RJ; Johannsen M; Nyegaard M; Mikkelsen JG; Kirchhoff F; Paludan SR; Jakobsen MR
Nat Commun; 2017 Feb; 8():14391. PubMed ID: 28186168
[TBL] [Abstract][Full Text] [Related]
30. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
[TBL] [Abstract][Full Text] [Related]
31. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
32. Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling.
An Y; Zhu J; Xie Q; Feng J; Gong Y; Fan Q; Cao J; Huang Z; Shi W; Lin Q; Wu L; Yang C; Ji T
Adv Sci (Weinh); 2024 May; 11(20):e2308131. PubMed ID: 38498770
[TBL] [Abstract][Full Text] [Related]
33. Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance.
Zhang L; DeBerge M; Wang J; Dangi A; Zhang X; Schroth S; Zhang Z; Thorp EB; Luo X
Am J Transplant; 2019 Mar; 19(3):674-685. PubMed ID: 30133807
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles.
Cheng AN; Cheng LC; Kuo CL; Lo YK; Chou HY; Chen CH; Wang YH; Chuang TH; Cheng SJ; Lee AY
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268351
[TBL] [Abstract][Full Text] [Related]
35. Potential Oncogenic Effect of the MERTK-Dependent Apoptotic-Cell Clearance Pathway in Starry-Sky B-Cell Lymphoma.
Farnworth-McHugh S; Barth N; Melville L; Paterson M; Lynch C; Holland P; Dransfield I; Gregory C
Front Immunol; 2020; 11():1759. PubMed ID: 32973744
[TBL] [Abstract][Full Text] [Related]
36. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
37. cGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity.
Liu H; Moura-Alves P; Pei G; Mollenkopf HJ; Hurwitz R; Wu X; Wang F; Liu S; Ma M; Fei Y; Zhu C; Koehler AB; Oberbeck-Mueller D; Hahnke K; Klemm M; Guhlich-Bornhof U; Ge B; Tuukkanen A; Kolbe M; Dorhoi A; Kaufmann SH
EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30872316
[TBL] [Abstract][Full Text] [Related]
38. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
[TBL] [Abstract][Full Text] [Related]
39. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
[TBL] [Abstract][Full Text] [Related]
40. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.
Dehn S; Thorp EB
FASEB J; 2018 Jan; 32(1):254-264. PubMed ID: 28860151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
